Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease
Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzh...
Saved in:
Published in | Journal of neurochemistry Vol. 156; no. 2; pp. 162 - 181 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.01.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-3042 1471-4159 1471-4159 |
DOI | 10.1111/jnc.15112 |
Cover
Abstract | Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
Blood‐derived exosomes as potential Alzheimer's disease biomarker resources. Exosomes can be secreted by the central nervous cells, including from neurons (in yellow) and astrocytes (in green) and cross the blood–brain barrier, being easily accessible in peripheral biofluids, like blood. These exosomes can transport Alzheimer's disease (AD) pathogenic content, as Aβ peptide (in red), Tau (the grey curved form) and P‐Tau proteins (the grey curved form with small red dots), but also nucleic acids (in black), supporting their use as suitable tools in biomarker discovery for AD diagnostics or therapeutics. |
---|---|
AbstractList | Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future. Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future. Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future. Blood‐derived exosomes as potential Alzheimer's disease biomarker resources. Exosomes can be secreted by the central nervous cells, including from neurons (in yellow) and astrocytes (in green) and cross the blood–brain barrier, being easily accessible in peripheral biofluids, like blood. These exosomes can transport Alzheimer's disease (AD) pathogenic content, as Aβ peptide (in red), Tau (the grey curved form) and P‐Tau proteins (the grey curved form with small red dots), but also nucleic acids (in black), supporting their use as suitable tools in biomarker discovery for AD diagnostics or therapeutics. |
Author | Campelo, Inês Trindade, Dário Vaz, Margarida Trigo, Guilherme da Cruz e Silva, Odete A. B. Soares Martins, Tânia Almeida, Martim Henriques, Ana Gabriela |
Author_xml | – sequence: 1 givenname: Tânia orcidid: 0000-0003-3017-2092 surname: Soares Martins fullname: Soares Martins, Tânia organization: University of Aveiro – sequence: 2 givenname: Dário orcidid: 0000-0002-8536-4609 surname: Trindade fullname: Trindade, Dário organization: University of Aveiro – sequence: 3 givenname: Margarida orcidid: 0000-0001-5425-1495 surname: Vaz fullname: Vaz, Margarida organization: University of Aveiro – sequence: 4 givenname: Inês surname: Campelo fullname: Campelo, Inês organization: University of Aveiro – sequence: 5 givenname: Martim surname: Almeida fullname: Almeida, Martim organization: University of Aveiro – sequence: 6 givenname: Guilherme surname: Trigo fullname: Trigo, Guilherme organization: University of Aveiro – sequence: 7 givenname: Odete A. B. orcidid: 0000-0003-3718-9874 surname: da Cruz e Silva fullname: da Cruz e Silva, Odete A. B. organization: University of Aveiro Campus – sequence: 8 givenname: Ana Gabriela orcidid: 0000-0003-0851-6979 surname: Henriques fullname: Henriques, Ana Gabriela email: aghenriques@ua.pt organization: University of Aveiro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32618370$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9O3DAQxq2Kqiy0h74AisSlPWTxOLbXOaItbUGIXtqz5Y0n4FViL3Yi_px4DV6PJ8GwuxdU5jKa0e_7NJpvj-z44JGQr0CnkOto6ZspCAD2gUyAz6DkIOodMqGUsbKinO2SvZSWlILkEj6R3YpJUNWMTsjpD2cufUiDawrjbTFcYTQrHF_mVRjQD850RWgLvA0p9JgK54vj7v4KXY_x6eExFdYlNAk_k4-t6RJ-2fR98u_nyd_57_L8z6_T-fF52XCoWamoFXUtamWUbWWlTMOplFSJGWsXswasyEsGglvGJfK2XrRWGBCWKiNtpap98m3tu4rhesQ06N6lBrvOeAxj0owzCpXglGb08A26DGP0-bpMKV5TqaDO1MGGGhc9Wr2KrjfxTm-flIGjNdDEkFLEVjduMIMLfojGdRqofolB5xj0awxZ8f2NYmv6P3bjfuM6vHsf1GcX87XiGfxPlRc |
CitedBy_id | crossref_primary_10_3390_ph15010076 crossref_primary_10_1002_pmic_202300063 crossref_primary_10_1186_s40779_023_00453_z crossref_primary_10_1016_j_critrevonc_2022_103628 crossref_primary_10_2147_JIR_S466821 crossref_primary_10_1007_s12035_022_02762_1 crossref_primary_10_3390_cancers14030732 crossref_primary_10_1002_alz_12723 crossref_primary_10_3389_fnins_2021_738442 crossref_primary_10_1021_acs_analchem_3c00215 crossref_primary_10_1111_prd_12561 crossref_primary_10_1111_jnc_16224 crossref_primary_10_3390_chemosensors11110554 crossref_primary_10_3389_fnagi_2022_785741 crossref_primary_10_3390_ijms241713161 crossref_primary_10_1111_jnc_15655 crossref_primary_10_1002_biof_1875 crossref_primary_10_1002_adbi_202400623 crossref_primary_10_3390_futurepharmacol5010011 crossref_primary_10_1016_j_heliyon_2023_e20604 crossref_primary_10_1016_j_lfs_2025_123468 crossref_primary_10_12677_acm_2024_1492563 crossref_primary_10_1080_21655979_2022_2026727 crossref_primary_10_1134_S1819712422020143 crossref_primary_10_1016_j_arr_2024_102483 crossref_primary_10_1111_jnc_70027 crossref_primary_10_1016_j_jsps_2023_101888 crossref_primary_10_1002_alz_14087 crossref_primary_10_1002_jev2_12233 crossref_primary_10_1016_j_lfs_2024_122987 crossref_primary_10_18632_aging_203508 crossref_primary_10_1007_s11064_022_03563_7 crossref_primary_10_2174_1567205019666220202120638 crossref_primary_10_3390_metabo13040479 crossref_primary_10_12677_ACM_2023_132185 crossref_primary_10_1186_s40035_022_00326_w crossref_primary_10_3390_jcm13226960 crossref_primary_10_1016_j_biocel_2022_106262 crossref_primary_10_3748_wjg_v30_i6_527 crossref_primary_10_1016_j_bios_2021_113864 crossref_primary_10_1007_s00216_022_04174_5 crossref_primary_10_1002_mco2_287 crossref_primary_10_1097_YCO_0000000000000842 crossref_primary_10_1016_j_bios_2025_117362 crossref_primary_10_1007_s10787_024_01466_3 crossref_primary_10_1016_j_bios_2023_115269 crossref_primary_10_1016_j_colsurfb_2024_113938 crossref_primary_10_1186_s13195_021_00791_x crossref_primary_10_5483_BMBRep_2022_55_1_162 crossref_primary_10_1021_acsami_3c16839 crossref_primary_10_1021_acsami_3c12766 crossref_primary_10_2174_0113862073261891231115072310 crossref_primary_10_1002_rcm_9427 crossref_primary_10_3390_antiox13030316 crossref_primary_10_1016_j_neubiorev_2022_104974 crossref_primary_10_3390_brainsci14111049 crossref_primary_10_3390_ijms242216259 crossref_primary_10_3390_ijms26010189 crossref_primary_10_1097_ONO_0000000000000027 crossref_primary_10_4103_NRR_NRR_D_24_00462 crossref_primary_10_1186_s43556_021_00040_5 crossref_primary_10_1016_j_bbrc_2025_151526 crossref_primary_10_3390_ijms23094610 crossref_primary_10_3390_ijms22179543 crossref_primary_10_1002_smll_202409806 crossref_primary_10_3389_fneur_2023_1059492 crossref_primary_10_1038_s41374_021_00644_z crossref_primary_10_3389_fnagi_2022_977411 crossref_primary_10_1002_adsr_202400002 crossref_primary_10_1111_jnc_15697 crossref_primary_10_1016_j_jsps_2023_01_009 crossref_primary_10_1016_j_critrevonc_2022_103799 crossref_primary_10_1038_s41538_024_00250_5 crossref_primary_10_1002_btm2_10203 crossref_primary_10_3390_ijms221910794 crossref_primary_10_1093_labmed_lmae039 crossref_primary_10_1080_08820139_2024_2440772 crossref_primary_10_3390_biomedicines9030252 crossref_primary_10_1159_000528886 crossref_primary_10_3390_ijms23158082 crossref_primary_10_1002_pmic_202200515 crossref_primary_10_1192_j_eurpsy_2022_2319 crossref_primary_10_3390_ijms22083933 crossref_primary_10_1016_j_cclet_2022_107926 crossref_primary_10_15616_BSL_2021_27_4_208 crossref_primary_10_3389_fgene_2023_1249678 crossref_primary_10_1016_j_jconrel_2022_06_011 crossref_primary_10_1093_stcltm_szad004 crossref_primary_10_1051_medsci_2024037 crossref_primary_10_3390_jcm12041459 crossref_primary_10_1016_j_biopha_2023_115407 crossref_primary_10_1515_mr_2023_0071 crossref_primary_10_3389_fncel_2020_590034 crossref_primary_10_1089_cell_2023_0001 crossref_primary_10_1097_MD_0000000000027319 crossref_primary_10_3390_ijms23147986 crossref_primary_10_3389_fnagi_2025_1496252 crossref_primary_10_3389_fncel_2021_743353 crossref_primary_10_1186_s13024_021_00474_z crossref_primary_10_3390_ijms22031365 crossref_primary_10_1155_2022_6742792 crossref_primary_10_1007_s12640_022_00621_4 crossref_primary_10_1016_j_ccr_2021_214325 crossref_primary_10_1038_s41368_022_00187_z crossref_primary_10_1007_s12013_024_01564_7 crossref_primary_10_3390_ijms25147794 crossref_primary_10_3390_ph16040540 crossref_primary_10_3389_fnagi_2022_860364 crossref_primary_10_2174_1574888X18666230726161035 crossref_primary_10_3390_pharmaceutics15041216 crossref_primary_10_1016_j_sciaf_2024_e02274 |
Cites_doi | 10.1371/journal.pone.0208580 10.3233/JAD-2009-1177 10.1074/jbc.M111.277061 10.1074/jbc.M114.605253 10.1002/prca.200700522 10.1016/S0006-291X(02)02999-6 10.3892/mmr.2014.2484 10.1074/jbc.M117.818138 10.1016/0092-8674(91)90459-C 10.1155/2018/8545347 10.3389/fnagi.2017.00012 10.1016/j.jconrel.2015.03.033 10.1073/pnas.0603838103 10.3233/JAD-132135 10.4132/jptm.2017.05.21 10.1186/s40478-017-0445-5 10.3233/JAD-142664 10.3389/fphar.2017.00910 10.3389/fncel.2019.00264 10.1186/1756-6606-6-47 10.7150/thno.21945 10.1242/jcs.115.12.2505 10.1186/s13024-016-0143-y 10.1007/s11011-019-00438-9 10.1111/j.1471-4159.2007.04587.x 10.1007/s00401-018-1868-1 10.1016/j.pharmthera.2018.08.002 10.4103/1673-5374.255978 10.1371/journal.pone.0041561 10.1523/JNEUROSCI.1429-16.2016 10.1016/j.bbamcr.2009.09.011 10.1016/j.dadm.2016.04.001 10.1038/srep07989 10.1016/j.devcel.2011.08.019 10.1016/j.mcn.2010.11.004 10.1096/fj.201600756R 10.1073/pnas.96.7.3922 10.1007/s11010-009-0084-7 10.1016/j.bbrc.2006.10.181 10.1083/jcb.201504136 10.1096/fj.14-262048 10.1080/21541248.2016.1264352 10.3402/jev.v3.24722 10.1007/s11064-019-02742-3 10.1016/j.febslet.2014.11.027 10.1083/jcb.200911018 10.1007/s12640-017-9713-1 10.1186/s13024-019-0333-5 10.1074/jbc.M110.149468 10.1073/pnas.0308512100 10.1007/s12031-007-0001-z 10.1074/jbc.273.43.27765 10.1523/JNEUROSCI.0387-15.2015 10.1111/bpa.12699 10.1096/fj.201700359 10.1038/s41467-017-02533-w 10.3389/fncel.2013.00182 10.1038/ncomms13588 10.1212/WNL.0000000000001702 10.1074/jbc.M609475200 10.1016/S0140-6736(06)69113-7 10.1016/j.neuroscience.2018.04.003 10.1074/jbc.M112.404467 10.3171/2014.11.JNS14770 10.1016/j.dadm.2018.11.002 10.1111/j.1600-0854.2009.00920.x 10.1146/annurev-cellbio-101512-122326 10.1186/s13024-017-0165-0 10.1038/npjamd.2016.19 10.1016/j.jalz.2014.06.008 10.7150/thno.18133 10.1007/s12035-018-1032-x 10.1074/jbc.M112.445304 10.2217/bmm-2018-0034 10.1039/C9NR01255A 10.1007/s10571-019-00751-y 10.1002/ana.25172 10.1042/bj3430371 10.3233/JAD-191034 10.1016/j.febslet.2008.05.002 10.3233/JAD-170278 10.3233/JAD-132144 10.1016/j.jalz.2016.08.012 10.1074/jbc.M110.134775 10.1038/nn.4132 10.2174/1567205016666190321155422 10.3390/ijms20071728 10.3389/fphar.2019.01452 10.1093/brain/awq258 10.1016/j.neurobiolaging.2014.02.012 10.1038/srep01197 10.1007/s11095-014-1593-y 10.1016/j.biochi.2018.05.015 10.1016/j.jalz.2019.06.4952 10.1038/nature14864 10.1007/s00702-008-0177-6 10.1096/fj.201600816R 10.2174/1567205014666170317113606 10.1007/s12035-019-1501-x 10.1096/fj.201700731R 10.1038/srep30319 10.1093/brain/awy289 10.1371/journal.pone.0198820 10.1038/cdd.2013.180 10.1016/j.jneumeth.2018.10.025 10.1186/s40035-019-0169-5 10.3233/JAD-2010-1371 10.1074/jbc.M111.324616 10.1186/s13024-017-0203-y 10.1101/cshperspect.a006270 10.1016/j.neuroscience.2018.03.016 10.3389/fnins.2018.00383 10.1016/j.nbd.2018.02.014 10.3389/fnins.2019.01208 10.3233/JAD-170176 10.1016/j.jalz.2019.05.002 10.1371/journal.pbio.1001604 10.1186/gm452 10.1096/fj.201801001 10.2174/187152710793237458 10.1016/j.brainres.2018.03.034 10.1111/j.1471-4159.2008.05770.x 10.3389/fncel.2019.00051 10.1074/jbc.M114.577213 10.1038/nbt.1807 10.1096/fj.201700600R 10.1007/7651_2014_98 10.1038/s41598-019-45676-0 10.1016/j.cub.2012.01.028 10.1038/s41582-018-0079-7 10.1155/2016/2584940 10.1096/fj.201801319R 10.1096/fj.07-9357com 10.1007/s12079-019-00524-8 10.3233/JAD-180578 10.1074/jbc.M115.709485 10.3233/JAD-2008-14103 10.2217/fon-2018-0812 10.18632/oncotarget.6158 10.3390/ijms19030663 10.1093/nar/gku594 10.1074/jbc.M112.340513 10.1038/ncb2000 10.1111/j.1600-0854.2004.00257.x 10.3233/JAD-2010-1206 10.1242/jcs.215210 10.3233/JAD-180776 10.1002/hbm.23494 10.1016/S0002-9440(10)64463-X 10.1007/s11064-018-2641-5 10.1038/mp.2014.127 10.1001/jamaneurol.2019.2462 10.1186/s40478-018-0514-4 10.1242/jcs.128868 10.1371/journal.pone.0139233 10.1038/s41467-019-09030-2 10.1016/j.neurobiolaging.2009.08.013 10.1126/science.1153124 10.1002/acn3.211 |
ContentType | Journal Article |
Copyright | 2020 International Society for Neurochemistry 2020 International Society for Neurochemistry. Copyright © 2021 International Society for Neurochemistry |
Copyright_xml | – notice: 2020 International Society for Neurochemistry – notice: 2020 International Society for Neurochemistry. – notice: Copyright © 2021 International Society for Neurochemistry |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 |
DOI | 10.1111/jnc.15112 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1471-4159 |
EndPage | 181 |
ExternalDocumentID | 32618370 10_1111_jnc_15112 JNC15112 |
Genre | reviewArticle Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: FCT stimulus of scientific employment individual support funderid: CEECIND/01803/2017 – fundername: FCT through the individual PhD grant funderid: SFRH/BD/145979/2019 – fundername: Integrated Programme of SR&TD “pAGE” ‐ CENTRO 2020 ‐ CENTRO‐01‐0145‐FEDER‐000003, co‐funded by Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund CENTRO 2020 – fundername: Alzheimer's Association Grant 2019‐AARG‐644347 – fundername: PTDC/DTPPIC/5587/2014 and POCI‐01‐0145‐FEDER‐016904 and also by Instituto de Biomedicina (iBiMED) ‐ UIDB/04501/2020, the Fundação para a Ciência e Tecnologia (FCT) of the Ministério da Educação e Ciência, COMPETE program, the QREN and the European Union (Fundo Europeu de Desenvolvimento Regional) |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c4192-80d599598a8df638ac406608572fb7c1d56382154d246e4f9bfd5a15d08a6d383 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 1471-4159 |
IngestDate | Fri Jul 11 04:14:54 EDT 2025 Fri Jul 25 19:32:13 EDT 2025 Thu Apr 03 07:07:47 EDT 2025 Tue Jul 01 04:39:38 EDT 2025 Thu Apr 24 22:59:00 EDT 2025 Wed Jan 22 16:32:06 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | diagnosis therapeutics biomarker Alzheimer's Disease exosome |
Language | English |
License | 2020 International Society for Neurochemistry. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4192-80d599598a8df638ac406608572fb7c1d56382154d246e4f9bfd5a15d08a6d383 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0003-0851-6979 0000-0003-3017-2092 0000-0003-3718-9874 0000-0001-5425-1495 0000-0002-8536-4609 |
PMID | 32618370 |
PQID | 2484906819 |
PQPubID | 31528 |
PageCount | 20 |
ParticipantIDs | proquest_miscellaneous_2420135400 proquest_journals_2484906819 pubmed_primary_32618370 crossref_citationtrail_10_1111_jnc_15112 crossref_primary_10_1111_jnc_15112 wiley_primary_10_1111_jnc_15112_JNC15112 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2021 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: January 2021 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Journal of neurochemistry |
PublicationTitleAlternate | J Neurochem |
PublicationYear | 2021 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2010; 12 2007; 102 2013; 3 2010; 19 2019; 11 2019; 10 2019; 13 2013; 126 2010; 189 2019; 15 2019; 14 2019; 16 2016; 30 2016; 2016 2013; 7 2018; 43 2013; 5 2013; 6 2008; 582 2016; 36 2014; 21 2009; 116 1998; 273 2018; 6 2018; 9 2018; 8 2010; 20 2009; 10 2019; 20 2019; 29 2008; 22 2007; 1 2018; 33 2018; 32 2012; 22 2018; 31 2009; 1793 2009; 18 2010; 9 2014; 10 2019; 8 2019; 9 2017; 60 2007; 282 2019; 33 2015; 122 2019; 34 2015; 1212 2010; 285 2015; 526 1999; 343 2014; 40 2015b; 85 2014; 42 2018; 19 2016; 6 2016; 7 2018; 192 2019; 40 2016; 2 2016; 3 2017; 58 1991; 65 2019; 44 2018; 114 2014; 35 2005; 6 2018; 12 2014; 30 2009; 108 2016; 291 2018; 14 2006; 103 2018; 13 2015; 35 2017; 5 2017; 7 2017; 8 2012; 287 2015; 589 2019; 56 2015; 32 2013; 288 2002; 115 2019; 405 2018; 83 2007; 32 2017; 9 2018; 131 2015; 45 2017; 31 2015; 290 2014; 3 2013; 11 2017; 38 2015; 211 2017; 32 2018; 379 2019; 69 2018; 136 2008; 319 2011; 21 2015a; 2 1999; 96 2006; 368 2009; 328 2011; 29 2014; 289 2004; 101 2015; 6 2015; 5 2015; 18 2017; 2017 2019; 76 2018; 1691 2015; 11 2015; 10 2008; 14 2017; 292 2011; 32 2015; 207 2018; 67 2019; 142 2018; 155 2012; 2 2018; 2018 2002; 161 2015; 29 2017; 14 2020; 74 2015; 20 2007; 352 2017; 13 2017; 12 2010; 133 2018; 52 2011; 46 2018; 319 2003; 301 2018; 55 2012; 7 e_1_2_9_75_1 e_1_2_9_98_1 e_1_2_9_52_1 e_1_2_9_79_1 e_1_2_9_94_1 e_1_2_9_10_1 e_1_2_9_56_1 e_1_2_9_33_1 e_1_2_9_90_1 e_1_2_9_71_1 e_1_2_9_103_1 e_1_2_9_126_1 e_1_2_9_149_1 e_1_2_9_107_1 e_1_2_9_122_1 e_1_2_9_145_1 e_1_2_9_14_1 e_1_2_9_141_1 e_1_2_9_37_1 e_1_2_9_18_1 e_1_2_9_160_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_87_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_83_1 e_1_2_9_6_1 e_1_2_9_119_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_138_1 e_1_2_9_111_1 e_1_2_9_134_1 e_1_2_9_115_1 e_1_2_9_157_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_130_1 e_1_2_9_153_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_99_1 e_1_2_9_72_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_95_1 e_1_2_9_76_1 e_1_2_9_91_1 e_1_2_9_102_1 e_1_2_9_148_1 e_1_2_9_129_1 e_1_2_9_144_1 e_1_2_9_106_1 e_1_2_9_125_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_140_1 e_1_2_9_121_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_88_1 e_1_2_9_61_1 e_1_2_9_46_1 e_1_2_9_84_1 e_1_2_9_23_1 e_1_2_9_65_1 e_1_2_9_80_1 e_1_2_9_5_1 e_1_2_9_114_1 e_1_2_9_137_1 e_1_2_9_118_1 e_1_2_9_133_1 e_1_2_9_156_1 e_1_2_9_9_1 e_1_2_9_152_1 e_1_2_9_27_1 e_1_2_9_69_1 e_1_2_9_110_1 e_1_2_9_31_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_35_1 e_1_2_9_77_1 e_1_2_9_96_1 e_1_2_9_12_1 e_1_2_9_54_1 e_1_2_9_92_1 e_1_2_9_109_1 e_1_2_9_101_1 e_1_2_9_128_1 Yang T. T. (e_1_2_9_154_1) 2018; 31 e_1_2_9_105_1 e_1_2_9_124_1 e_1_2_9_147_1 e_1_2_9_39_1 e_1_2_9_162_1 e_1_2_9_120_1 e_1_2_9_16_1 e_1_2_9_58_1 e_1_2_9_143_1 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_89_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_85_1 e_1_2_9_8_1 e_1_2_9_81_1 e_1_2_9_4_1 e_1_2_9_113_1 e_1_2_9_159_1 e_1_2_9_117_1 e_1_2_9_155_1 e_1_2_9_136_1 e_1_2_9_151_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_132_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_78_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_97_1 e_1_2_9_93_1 e_1_2_9_108_1 e_1_2_9_70_1 e_1_2_9_127_1 e_1_2_9_100_1 e_1_2_9_123_1 e_1_2_9_104_1 e_1_2_9_146_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 Wang L.‐L. (e_1_2_9_142_1) 2017; 2017 e_1_2_9_161_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_21_1 e_1_2_9_67_1 e_1_2_9_44_1 e_1_2_9_86_1 e_1_2_9_7_1 e_1_2_9_82_1 e_1_2_9_3_1 e_1_2_9_112_1 e_1_2_9_139_1 e_1_2_9_116_1 e_1_2_9_135_1 e_1_2_9_158_1 e_1_2_9_25_1 e_1_2_9_131_1 e_1_2_9_48_1 e_1_2_9_29_1 e_1_2_9_150_1 |
References_xml | – volume: 9 start-page: 720 year: 2010 end-page: 726 article-title: Wnt signalling is a relevant pathway contributing to amyloid beta‐peptide‐mediated neuropathology in Alzheimers disease publication-title: CNS & Neurological Disorders – Drug Targets – volume: 368 start-page: 387 year: 2006 end-page: 403 article-title: Alzheimer’s disease publication-title: Lancet – volume: 2016 start-page: 2584940 year: 2016 article-title: Differential DNA methylation of microRNA genes in temporal cortex from Alzheimer’s disease individuals publication-title: Neural Plasticity – volume: 32 start-page: 2003 year: 2015 end-page: 2014 article-title: Exosome delivered anticancer drugs across the blood‐brain barrier for brain cancer therapy in Danio rerio publication-title: Pharmaceutical Research – volume: 35 start-page: 10851 year: 2015 end-page: 10865 article-title: C‐terminally truncated forms of tau, but not full‐length tau or its C‐terminal fragments, are released from neurons independently of cell death publication-title: Journal of Neuroscience – volume: 1212 start-page: 171 year: 2015 end-page: 181 article-title: Potential application of extracellular vesicles of human adipose tissue‐derived mesenchymal stem cells in Alzheimer’s disease therapeutics publication-title: Methods in Molecular Biology – volume: 287 start-page: 10977 year: 2012 end-page: 10989 article-title: Sphingolipid‐modulated exosome secretion promotes clearance of amyloid‐β by microglia publication-title: Journal of Biological Chemistry – volume: 96 start-page: 3922 year: 1999 end-page: 3927 article-title: Constitutive and regulated alpha‐secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease publication-title: Proceedings of the National Academy of Sciences of the United States of America – volume: 10 start-page: 2395 year: 2014 end-page: 2400 article-title: MicroRNA‐193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA‐193b is a biomarker of Alzheimer’s disease publication-title: Molecular Medicine Reports – volume: 589 start-page: 84 year: 2015 end-page: 88 article-title: A potential function for neuronal exosomes: Sequestering intracerebral amyloid‐β peptide publication-title: FEBS Letters – volume: 13 start-page: 264 year: 2019 article-title: Glutaminase C regulates microglial activation and pro‐inflammatory exosome release: Relevance to the pathogenesis of Alzheimer’s disease publication-title: Frontiers in Cellular Neuroscience – volume: 133 start-page: 3699 year: 2010 end-page: 3723 article-title: Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer’s disease publication-title: Brain – volume: 15 start-page: 1071 year: 2019 end-page: 1080 article-title: Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association – volume: 20 start-page: 275 year: 2010 end-page: 292 article-title: Grb2‐mediated alteration in the trafficking of AbetaPP: Insights from Grb2‐AICD interaction publication-title: Journal of Alzheimer's Disease – volume: 6 start-page: 131 year: 2005 end-page: 143 article-title: Rab11 promotes docking and fusion of multivesicular bodies in a calcium‐dependent manner publication-title: Traffic – volume: 10 start-page: 925 year: 2009 end-page: 937 article-title: Multivesicular endosome Biogenesis in the absence of ESCRTs publication-title: Traffic – volume: 379 start-page: 167 year: 2018 end-page: 176 article-title: Serum exosomal miR‐223 serves as a potential diagnostic and prognostic biomarker for dementia publication-title: Neuroscience – volume: 36 start-page: 8653 year: 2016 end-page: 8667 article-title: Neutral sphingomyelinase‐2 deficiency ameliorates Alzheimer’s disease pathology and improves cognition in the 5XFAD mouse publication-title: Journal of Neuroscience – volume: 5 start-page: 46 year: 2017 article-title: Brain‐derived exosomes from dementia with Lewy bodies propagate α‐synuclein pathology publication-title: Acta Neuropathologica Communications – volume: 8 start-page: 910 year: 2017 article-title: ATP modifies the proteome of extracellular vesicles released by microglia and influences their action on astrocytes publication-title: Frontiers in Pharmacology – volume: 114 start-page: 120 year: 2018 end-page: 128 article-title: Neuronal pentraxin 1: A synaptic‐derived plasma biomarker in Alzheimer’s disease publication-title: Neurobiology of Diseases – volume: 3 start-page: 63 year: 2016 end-page: 72 article-title: Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile publication-title: Alzheimer’s Dement – volume: 161 start-page: 1869 year: 2002 end-page: 1879 article-title: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology publication-title: American Journal of Pathology – volume: 35 start-page: 1792 year: 2014 end-page: 1800 article-title: Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease publication-title: Neurobiology of Aging – volume: 38 start-page: 1933 year: 2017 end-page: 1940 article-title: Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer’s disease publication-title: Human Brain Mapping – volume: 2 start-page: 16019 year: 2016 article-title: Extracellular vesicle‐associated Aβ mediates trans‐neuronal bioenergetic and Ca2+‐handling deficits in Alzheimer’s disease models publication-title: NPJ Aging and Mechanisms of Disease. – volume: 20 start-page: 1188 year: 2015 end-page: 1196 article-title: Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment publication-title: Molecular Psychiatry – volume: 13 year: 2018 article-title: Exosome isolation from distinct biofluids using precipitation and column‐based approaches publication-title: PLoS One – volume: 22 start-page: R116 year: 2012 end-page: R120 article-title: The ESCRT machinery publication-title: Current Biology – volume: 12 start-page: 5 year: 2017 article-title: The release and trans‐synaptic transmission of Tau via exosomes publication-title: Molecular Neurodegeneration – volume: 11 start-page: 61 year: 2019 end-page: 66 article-title: Complement protein levels in plasma astrocyte‐derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer’s disease dementia publication-title: Alzheimer’s Dement. (amsterdam, Netherlands) – volume: 32 start-page: 1435 year: 2011 end-page: 1442 article-title: Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer’s disease publication-title: Neurobiology of Aging – volume: 52 start-page: 1 year: 2018 end-page: 8 article-title: Extracellular vesicles and the promise of continuous liquid biopsies publication-title: Journal of Pathology and Translational Medicine – volume: 13 start-page: 1208 year: 2019 article-title: miR‐212 and miR‐132 are downregulated in neurally derived plasma exosomes of Alzheimer’s patients publication-title: Frontiers in Neuroscience – volume: 14 start-page: 639 year: 2018 end-page: 652 article-title: Blood‐based biomarkers for Alzheimer disease: Mapping the road to the clinic publication-title: Nature Reviews. Neurology – volume: 15 start-page: 801 year: 2019 end-page: 803 article-title: Why have microRNA biomarkers not been translated from bench to clinic? publication-title: Future Oncology – volume: 5 start-page: 48 year: 2013 article-title: Genes and pathways underlying regional and cell type changes in Alzheimer’s disease publication-title: Genome Medicine – volume: 12 start-page: 19 year: 2010 end-page: 30 article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway publication-title: Nature Cell Biology – volume: 189 start-page: 223 year: 2010 end-page: 232 article-title: Regulation of exosome secretion by Rab35 and its GTPase‐activating proteins TBC1D10A–C publication-title: Journal of Cell Biology – volume: 10 start-page: 1452 year: 2019 article-title: Exosomes from astrocyte processes: Signaling to neurons publication-title: Front. Pharmacol. – volume: 282 start-page: 18197 year: 2007 end-page: 18205 article-title: Alkalizing drugs induce accumulation of amyloid precursor protein by‐products in luminal vesicles of multivesicular bodies publication-title: Journal of Biological Chemistry – volume: 102 start-page: 619 year: 2007 end-page: 626 article-title: Alzheimer’s presenilin 1 modulates sorting of APP and its carboxyl‐terminal fragments in cerebral neurons in vivo publication-title: Journal of Neurochemistry – volume: 1 start-page: 1446 year: 2007 end-page: 1461 article-title: Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons? publication-title: Proteomics ‐ Clin. Appl. – volume: 40 start-page: 1017 year: 2014 end-page: 1027 article-title: Genome‐wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer’s disease publication-title: Journal of Alzheimer's Disease – volume: 3 start-page: 1 year: 2014 article-title: Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons publication-title: Journal of Extracellular Vesicles – volume: 12 start-page: 25 year: 2017 article-title: Tetraspanin 6: A pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments publication-title: Molecular Neurodegeneration – volume: 10 year: 2015 article-title: Plasma exosomal miRNAs in Persons with and without Alzheimer Disease: Altered expression and prospects for biomarkers publication-title: PLoS One – volume: 13 year: 2018 article-title: MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study publication-title: PLoS One – volume: 207 start-page: 18 year: 2015 end-page: 30 article-title: Exosomes as drug delivery vehicles for Parkinson’s disease therapy publication-title: J. Control. Release – volume: 9 start-page: 291 year: 2018 article-title: Neuronal lysosomal dysfunction releases exosomes harboring APP C‐terminal fragments and unique lipid signatures publication-title: Nature Communications – volume: 3 start-page: 1197 year: 2013 article-title: Human adipose tissue‐derived mesenchymal stem cells secrete functional neprilysin‐bound exosomes publication-title: Scientific Reports – volume: 15 start-page: 1468 year: 2019 end-page: 1477 article-title: Differential expression of microRNAs in Alzheimer’s disease brain, blood, and cerebrospinal fluid publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association – volume: 301 start-page: 231 year: 2003 end-page: 235 article-title: Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha‐secretase publication-title: Biochemical and Biophysical Research Communications – volume: 22 start-page: 1469 year: 2008 end-page: 1478 article-title: Inhibition of gamma‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes publication-title: The FASEB Journal – volume: 30 start-page: 4141 year: 2016 end-page: 4148 article-title: Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s disease publication-title: The FASEB Journal – volume: 19 start-page: 663 year: 2018 article-title: Detection of aggregation‐competent tau in neuron‐derived extracellular vesicles publication-title: International Journal of Molecular Sciences – volume: 7 year: 2012 article-title: Comparing the MicroRNA spectrum between serum and plasma publication-title: PLoS One – volume: 11 start-page: 600 year: 2015 end-page: 607 article-title: Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study publication-title: Alzheimer's & Dementia: the Journal of the Alzheimer's Association – volume: 7 start-page: 13588 year: 2016 article-title: ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins publication-title: Nature Communications – volume: 9 start-page: 95 year: 2018 end-page: 106 article-title: New insights into the function of Rab GTPases in the context of exosomal secretion publication-title: Small GTPases – volume: 6 start-page: 30319 year: 2016 article-title: Altered protein phosphorylation as a resource for potential AD biomarkers publication-title: Scientific Reports – volume: 291 start-page: 12445 year: 2016 end-page: 12466 article-title: Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold‐dependent manner publication-title: Journal of Biological Chemistry – volume: 155 start-page: 67 year: 2018 end-page: 82 article-title: Secretome from SH‐SY5Y APPSwe cells trigger time‐dependent CHME3 microglia activation phenotypes, ultimately leading to miR‐21 exosome shuttling publication-title: Biochimie – volume: 352 start-page: 111 year: 2007 end-page: 117 article-title: ADAM19 is tightly associated with constitutive Alzheimer’s disease APP α‐secretase in A172 cells publication-title: Biochemical and Biophysical Research Communications – volume: 290 start-page: 3455 year: 2015 end-page: 3467 article-title: The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes publication-title: Journal of Biological Chemistry – volume: 34 start-page: 1355 year: 2019 end-page: 1363 article-title: Intrahippocampal miR‐342‐3p inhibition reduces β‐amyloid plaques and ameliorates learning and memory in Alzheimer’s disease publication-title: Metabolic Brain Disease – volume: 31 start-page: 2729 year: 2017 end-page: 2743 article-title: Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer’s disease: Inseparable partners in a multifactorial disease publication-title: The FASEB Journal – volume: 31 start-page: 87 year: 2018 end-page: 96 article-title: The serum exosome derived microRNA‐135a, ‐193b, and ‐384 were potential Alzheimer’s disease biomarkers publication-title: Biomedical and Environmental Sciences – volume: 13 start-page: 51 year: 2019 article-title: Extracellular vesicles secreted in response to cytokine exposure increase mitochondrial oxygen consumption in recipient cells publication-title: Frontiers in Cellular Neuroscience – volume: 328 start-page: 145 year: 2009 end-page: 154 article-title: S655 phosphorylation enhances APP secretory traffic publication-title: Molecular and Cellular Biochemistry – volume: 18 start-page: 413 year: 2009 end-page: 417 article-title: Cerebrospinal fluid biomarkers for Alzheimer’s disease publication-title: Journal of Alzheimer's Disease – volume: 131 start-page: jcs215210 year: 2018 article-title: The interplay between exosomes and autophagy ‐ partners in crime publication-title: Journal of Cell Science – volume: 122 start-page: 856 year: 2015 end-page: 867 article-title: Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury publication-title: Journal of Neurosurgery – volume: 14 start-page: 870 year: 2017 end-page: 882 article-title: Impact of cytokines and chemokines on Alzheimer’s disease neuropathological hallmarks publication-title: Current Alzheimer Research – volume: 405 start-page: 148 year: 2019 end-page: 157 article-title: Cell‐to‐cell communication by extracellular vesicles: focus on microglia publication-title: Neuroscience – volume: 319 start-page: 1244 year: 2008 end-page: 1247 article-title: Ceramide triggers budding of exosome vesicles into multivesicular endosomes publication-title: Science (80‐. ) – volume: 32 start-page: 1 year: 2007 end-page: 8 article-title: Tyr687 dependent APP endocytosis and Abeta production publication-title: Journal of Molecular Neuroscience – volume: 55 start-page: 8826 year: 2018 end-page: 8841 article-title: MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young‐onset Alzheimer’s disease publication-title: Molecular Neurobiology – volume: 142 start-page: 163 year: 2019 end-page: 175 article-title: Apolipoprotein E4 genotype compromises brain exosome production publication-title: Brain – volume: 287 start-page: 21384 year: 2012 end-page: 21395 article-title: Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR‐4): Potential mechanism of apoptosis induction in Alzheimer disease (AD) publication-title: Journal of Biological Chemistry – volume: 69 start-page: 489 year: 2019 end-page: 498 article-title: Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer’s disease publication-title: Journal of Alzheimer's Disease – volume: 58 start-page: 953 year: 2017 end-page: 978 article-title: Protein phosphorylation is a key mechanism in Alzheimer’s Disease publication-title: Journal of Alzheimer's Disease – volume: 101 start-page: 2173 year: 2004 end-page: 2178 article-title: Incipient Alzheimer’s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses publication-title: Proceedings of the National Academy of Sciences – volume: 29 start-page: 593 year: 2019 end-page: 605 article-title: Brain‐derived and circulating vesicle profiles indicate neurovascular unit dysfunction in early Alzheimer’s disease publication-title: Brain Pathology – volume: 42 start-page: 9195 year: 2014 end-page: 9208 article-title: Activity‐associated miRNA are packaged in Map1b‐enriched exosomes released from depolarized neurons publication-title: Nucleic Acids Research – volume: 115 start-page: 2505 year: 2002 end-page: 2515 article-title: The exosome pathway in K562 cells is regulated by Rab11 publication-title: Journal of Cell Science – volume: 14 start-page: 32 year: 2019 article-title: The neuropathological diagnosis of Alzheimer’s disease publication-title: Molecular Neurodegeneration – volume: 12 start-page: 1025 year: 2018 end-page: 1033 article-title: Exosomes as possible spread factor and potential biomarkers in Alzheimer’s disease: Current concepts publication-title: Biomark. Med. – volume: 292 start-page: 19873 year: 2017 end-page: 19889 article-title: Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2‐mediated cleavage publication-title: Journal of Biological Chemistry – volume: 116 start-page: 203 year: 2009 end-page: 212 article-title: Combined CSF tau, p‐tau181 and amyloid‐beta 38/40/42 for diagnosing Alzheimer’s disease publication-title: Journal of Neural Transmission – volume: 32 start-page: 888 year: 2018 end-page: 893 article-title: Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer’s disease publication-title: The FASEB Journal – volume: 46 start-page: 409 year: 2011 end-page: 418 article-title: Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity publication-title: Molecular and Cellular Neurosciences – volume: 526 start-page: 443 year: 2015 end-page: 447 article-title: η‐Secretase processing of APP inhibits neuronal activity in the hippocampus publication-title: Nature – volume: 6 start-page: 37043 year: 2015 end-page: 37053 article-title: Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease publication-title: Oncotarget – volume: 18 start-page: 1584 year: 2015 end-page: 1593 article-title: Depletion of microglia and inhibition of exosome synthesis halt tau propagation publication-title: Nature Neuroscience – volume: 13 start-page: 541 year: 2017 end-page: 549 article-title: Neuronal exosomes reveal Alzheimer’s disease biomarkers in Down syndrome publication-title: Alzheimer’s Dement – volume: 32 start-page: 82 year: 2017 end-page: 93 article-title: Exosomes secreted from HEK293‐APP Swe/Ind cells impair the hippocampal neurogenesis publication-title: Neurotoxicity Research – volume: 29 start-page: 589 year: 2015 end-page: 596 article-title: Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer’s disease publication-title: The FASEB Journal – volume: 40 start-page: 531 year: 2019 end-page: 546 article-title: Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular‐related diseases publication-title: Cellular and Molecular Neurobiology – volume: 273 start-page: 27765 year: 1998 end-page: 27767 article-title: Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha‐secretase cleavage of the Alzheimer amyloid protein precursor publication-title: Journal of Biological Chemistry – volume: 67 start-page: 541 year: 2018 end-page: 553 article-title: Neuronal exosome‐derived human tau is toxic to recipient mouse neurons in vivo publication-title: Journal of Alzheimer's Disease – volume: 285 start-page: 26279 year: 2010 end-page: 26288 article-title: Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann‐Pick type C disease publication-title: Journal of Biological Chemistry – volume: 6 start-page: 47 year: 2013 article-title: Exosomes neutralize synaptic‐plasticity‐disrupting activity of Aβ assemblies in vivo publication-title: Molecular Brain – volume: 9 start-page: 9477 year: 2019 article-title: BIN1 favors the spreading of Tau via extracellular vesicles publication-title: Scientific Reports – volume: 192 start-page: 170 year: 2018 end-page: 187 article-title: Extracellular vesicles and their nucleic acids for biomarker discovery publication-title: Pharmacology & Therapeutics – volume: 108 start-page: 319 year: 2009 end-page: 330 article-title: Enhanced generation of Alzheimer’s amyloid‐β following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C publication-title: Journal of Neurochemistry – volume: 582 start-page: 1865 year: 2008 end-page: 1870 article-title: p3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers publication-title: FEBS Letters – volume: 8 start-page: 31 year: 2019 article-title: Exploratory study on microRNA profiles from plasma‐derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies publication-title: Transl. Neurodegener. – volume: 12 start-page: 383 year: 2018 article-title: Alzheimer’s disease and Type 2 diabetes: A critical assessment of the shared pathological traits publication-title: Frontiers in Neuroscience – volume: 12 start-page: 61 year: 2017 article-title: Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A publication-title: Molecular Neurodegeneration – volume: 11 start-page: 7481 year: 2019 end-page: 7496 article-title: Curcumin‐primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK‐3β pathway publication-title: Nanoscale – volume: 2 start-page: 769 year: 2015a end-page: 773 article-title: Low neural exosomal levels of cellular survival factors in Alzheimer’s disease publication-title: Annals of Clinical and Translational Neurology – volume: 76 start-page: 1340 year: 2019 end-page: 1351 article-title: Association of extracellular vesicle biomarkers with alzheimer disease in the baltimore longitudinal study of aging publication-title: JAMA Neurology – volume: 33 start-page: 3758 year: 2018 end-page: 3771 article-title: Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes publication-title: The FASEB Journal – volume: 32 start-page: 654 year: 2017 end-page: 668 article-title: Exosomes derived from hypoxia‐preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice publication-title: The FASEB Journal – volume: 45 start-page: 495 year: 2015 end-page: 507 article-title: Amyloid‐β modulates both AβPP and tau phosphorylation publication-title: Journal of Alzheimer's Disease – volume: 126 start-page: 5553 year: 2013 end-page: 5565 article-title: Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles publication-title: Journal of Cell Science – volume: 21 start-page: 582 year: 2014 end-page: 593 article-title: Microglia convert aggregated amyloid‐β into neurotoxic forms through the shedding of microvesicles publication-title: Cell Death and Differentiation – volume: 2018 start-page: 1 year: 2018 end-page: 27 article-title: Isolation of extracellular vesicles: general methodologies and latest trends publication-title: BioMed Research International – volume: 30 start-page: 3853 year: 2016 end-page: 3859 article-title: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer’s disease publication-title: The FASEB Journal – volume: 2017 start-page: 8030369 year: 2017 article-title: Profiling microRNA from brain by microarray in a transgenic mouse model of Alzheimer’s disease publication-title: BioMed Research International – volume: 14 start-page: 27 year: 2008 end-page: 41 article-title: Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways publication-title: Journal of Alzheimer's Disease – volume: 8 start-page: 237 year: 2018 end-page: 255 article-title: Exosome theranostics: biology and translational medicine publication-title: Theranostics – volume: 14 start-page: 1626 year: 2019 end-page: 1634 article-title: Mesenchymal stem cell‐derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer’s disease publication-title: Neural Regeneration Research – volume: 21 start-page: 708 year: 2011 end-page: 721 article-title: The tetraspanin CD63 regulates ESCRT‐independent and ‐dependent endosomal sorting during melanogenesis publication-title: Developmental Cell – volume: 19 start-page: 79 year: 2010 end-page: 95 article-title: Insulin‐degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid‐beta degrading protease publication-title: Journal of Alzheimer's Disease – volume: 20 start-page: 1728 year: 2019 article-title: Extracellular vesicle as a source of Alzheimer’s biomarkers: opportunities and challenges publication-title: International Journal of Molecular Sciences – volume: 74 start-page: 391 year: 2020 end-page: 405 article-title: Potential of FTIR spectroscopy applied to exosomes for Alzheimer’s disease discrimination: A pilot study publication-title: Journal of Alzheimer's Disease – volume: 83 start-page: 544 year: 2018 end-page: 552 article-title: High complement levels in astrocyte‐derived exosomes of Alzheimer disease publication-title: Annals of Neurology – volume: 56 start-page: 5792 year: 2019 end-page: 5798 article-title: SNAP‐25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer’s disease publication-title: Molecular Neurobiology – volume: 13 start-page: 443 year: 2019 end-page: 450 article-title: Exosomes and autophagy: Rekindling the vesicular waste hypothesis publication-title: Journal of Cell Communication and Signaling – volume: 29 start-page: 341 year: 2011 end-page: 345 article-title: Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes publication-title: Nature Biotechnology – volume: 288 start-page: 11649 year: 2013 end-page: 11661 article-title: The intracellular interactome of tetraspanin‐enriched microdomains reveals their function as sorting machineries toward exosomes publication-title: Journal of Biological Chemistry – volume: 33 start-page: 231 year: 2019 end-page: 238 article-title: Deficient neurotrophic factors of CSPG4‐type neural cell exosomes in Alzheimer disease publication-title: The FASEB Journal – volume: 287 start-page: 3842 year: 2012 end-page: 3849 article-title: Exosome‐associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease publication-title: Journal of Biological Chemistry – volume: 11 year: 2013 article-title: Neurotransmitter‐triggered transfer of exosomes mediates oligodendrocyte‐neuron communication publication-title: PLoS Biology – volume: 60 start-page: 305 year: 2017 end-page: 321 article-title: Increased release of apolipoprotein e in extracellular vesicles following amyloid‐β protofibril exposure of neuroglial co‐cultures publication-title: Journal of Alzheimer's Disease – volume: 287 start-page: 43108 year: 2012 end-page: 43115 article-title: The exosome secretory pathway transports amyloid precursor protein carboxyl‐terminal fragments from the cell into the brain extracellular space publication-title: Journal of Biological Chemistry – volume: 43 start-page: 2165 year: 2018 end-page: 2177 article-title: Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid‐beta deposition by modulating microglial activation in alzheimer’s disease publication-title: Neurochemical Research – volume: 9 start-page: 12 year: 2017 article-title: Plasma exosomes spread and cluster around β‐amyloid plaques in an animal model of Alzheimer’s disease publication-title: Frontiers in Aging Neuroscience – volume: 65 start-page: 417 year: 1991 end-page: 427 article-title: Late endosomes derive from early endosomes by maturation publication-title: Cell – volume: 30 start-page: 255 year: 2014 end-page: 289 article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles publication-title: Annual Review of Cell and Developmental Biology – volume: 289 start-page: 24488 year: 2014 end-page: 24498 article-title: Decreased amyloid‐β pathologies by intracerebral loading of glycosphingolipid‐enriched exosomes in Alzheimer model mice publication-title: Journal of Biological Chemistry – volume: 5 start-page: 7989 year: 2015 article-title: Neuronal exosomes facilitate synaptic pruning by up‐regulating complement factors in microglia publication-title: Scientific Reports – volume: 1691 start-page: 87 year: 2018 end-page: 93 article-title: The exosome of adipose‐derived stem cells reduces β‐amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer’s disease publication-title: Brain Research – volume: 16 start-page: 388 year: 2019 end-page: 395 article-title: Characterization of serum exosomes from a transgenic mouse model of Alzheimer’s disease publication-title: Current Alzheimer Research – volume: 85 start-page: 40 year: 2015b end-page: 47 article-title: Altered lysosomal proteins in neural‐derived plasma exosomes in preclinical Alzheimer disease publication-title: Neurology – volume: 7 start-page: 182 year: 2013 article-title: Extracellular vesicles as mediators of neuron‐glia communication publication-title: Frontiers in Cellular Neuroscience – volume: 1793 start-page: 1901 year: 2009 end-page: 1916 article-title: TI‐VAMP/VAMP7 and VAMP3/cellubrevin: Two v‐SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways publication-title: Biochimica Et Biophysica Acta ‐ Molecular Cell Research – volume: 343 start-page: 371 issue: Pt 2 year: 1999 end-page: 375 article-title: Membrane‐anchored metalloprotease MDC9 has an alpha‐secretase activity responsible for processing the amyloid precursor protein publication-title: The Biochemical Journal – volume: 44 start-page: 1113 year: 2019 end-page: 1126 article-title: Resveratrol abrogates hypoxia‐induced up‐regulation of exosomal amyloid‐β partially by inhibiting CD147 publication-title: Neurochemical Research – volume: 211 start-page: 27 year: 2015 end-page: 37 article-title: RAL‐1 controls multivesicular body biogenesis and exosome secretion publication-title: Journal of Cell Biology – volume: 7 start-page: 789 year: 2017 end-page: 804 article-title: Progress in exosome isolation techniques publication-title: Theranostics – volume: 136 start-page: 41 year: 2018 end-page: 56 article-title: Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid‐beta oligomers publication-title: Acta Neuropathologica – volume: 2 start-page: a006270 year: 2012 article-title: Trafficking and proteolytic processing of APP publication-title: Cold Spring Harbor Perspectives in Medicine – volume: 319 start-page: 2 year: 2018 end-page: 6 article-title: Blood‐based biomarkers for Alzheimer’s disease—An update publication-title: Journal of Neuroscience Methods – volume: 103 start-page: 11172 year: 2006 end-page: 11177 article-title: Alzheimer’s disease beta‐amyloid peptides are released in association with exosomes publication-title: Proceedings of the National Academy of Sciences of the United States of America – volume: 6 start-page: 10 year: 2018 article-title: Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons publication-title: Acta Neuropathologica Communications – volume: 285 start-page: 37405 year: 2010 end-page: 37414 article-title: Statins promote the degradation of extracellular amyloid beta‐peptide by microglia via stimulation of exosome‐associated insulin‐degrading enzyme (IDE) secretion publication-title: Journal of Biological Chemistry – volume: 10 start-page: 1144 year: 2019 article-title: Subtyping of circulating exosome‐bound amyloid β reflects brain plaque deposition publication-title: Nature Communications – volume: 40 start-page: S47 issue: Suppl 1 year: 2014 end-page: 70 article-title: Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer’s disease publication-title: Journal of Alzheimer's Disease – ident: e_1_2_9_77_1 doi: 10.1371/journal.pone.0208580 – ident: e_1_2_9_13_1 doi: 10.3233/JAD-2009-1177 – ident: e_1_2_9_115_1 doi: 10.1074/jbc.M111.277061 – ident: e_1_2_9_59_1 doi: 10.1074/jbc.M114.605253 – ident: e_1_2_9_78_1 doi: 10.1002/prca.200700522 – ident: e_1_2_9_7_1 doi: 10.1016/S0006-291X(02)02999-6 – ident: e_1_2_9_85_1 doi: 10.3892/mmr.2014.2484 – ident: e_1_2_9_148_1 doi: 10.1074/jbc.M117.818138 – ident: e_1_2_9_124_1 doi: 10.1016/0092-8674(91)90459-C – ident: e_1_2_9_76_1 doi: 10.1155/2018/8545347 – ident: e_1_2_9_162_1 doi: 10.3389/fnagi.2017.00012 – ident: e_1_2_9_63_1 doi: 10.1016/j.jconrel.2015.03.033 – ident: e_1_2_9_108_1 doi: 10.1073/pnas.0603838103 – ident: e_1_2_9_116_1 doi: 10.3233/JAD-132135 – ident: e_1_2_9_5_1 doi: 10.4132/jptm.2017.05.21 – ident: e_1_2_9_94_1 doi: 10.1186/s40478-017-0445-5 – ident: e_1_2_9_98_1 doi: 10.3233/JAD-142664 – ident: e_1_2_9_33_1 doi: 10.3389/fphar.2017.00910 – ident: e_1_2_9_45_1 doi: 10.3389/fncel.2019.00264 – ident: e_1_2_9_4_1 doi: 10.1186/1756-6606-6-47 – ident: e_1_2_9_64_1 doi: 10.7150/thno.21945 – ident: e_1_2_9_119_1 doi: 10.1242/jcs.115.12.2505 – ident: e_1_2_9_143_1 doi: 10.1186/s13024-016-0143-y – ident: e_1_2_9_41_1 doi: 10.1007/s11011-019-00438-9 – ident: e_1_2_9_44_1 doi: 10.1111/j.1471-4159.2007.04587.x – ident: e_1_2_9_117_1 doi: 10.1007/s00401-018-1868-1 – ident: e_1_2_9_91_1 doi: 10.1016/j.pharmthera.2018.08.002 – ident: e_1_2_9_111_1 doi: 10.4103/1673-5374.255978 – ident: e_1_2_9_141_1 doi: 10.1371/journal.pone.0041561 – ident: e_1_2_9_31_1 doi: 10.1523/JNEUROSCI.1429-16.2016 – ident: e_1_2_9_36_1 doi: 10.1016/j.bbamcr.2009.09.011 – ident: e_1_2_9_150_1 doi: 10.1016/j.dadm.2016.04.001 – ident: e_1_2_9_8_1 doi: 10.1038/srep07989 – ident: e_1_2_9_133_1 doi: 10.1016/j.devcel.2011.08.019 – ident: e_1_2_9_79_1 doi: 10.1016/j.mcn.2010.11.004 – ident: e_1_2_9_51_1 doi: 10.1096/fj.201600756R – ident: e_1_2_9_80_1 doi: 10.1073/pnas.96.7.3922 – ident: e_1_2_9_135_1 doi: 10.1007/s11010-009-0084-7 – ident: e_1_2_9_131_1 doi: 10.1016/j.bbrc.2006.10.181 – ident: e_1_2_9_67_1 doi: 10.1083/jcb.201504136 – ident: e_1_2_9_71_1 doi: 10.1096/fj.14-262048 – ident: e_1_2_9_11_1 doi: 10.1080/21541248.2016.1264352 – ident: e_1_2_9_20_1 doi: 10.3402/jev.v3.24722 – ident: e_1_2_9_152_1 doi: 10.1007/s11064-019-02742-3 – ident: e_1_2_9_158_1 doi: 10.1016/j.febslet.2014.11.027 – ident: e_1_2_9_66_1 doi: 10.1083/jcb.200911018 – ident: e_1_2_9_161_1 doi: 10.1007/s12640-017-9713-1 – ident: e_1_2_9_28_1 doi: 10.1186/s13024-019-0333-5 – ident: e_1_2_9_129_1 doi: 10.1074/jbc.M110.149468 – ident: e_1_2_9_10_1 doi: 10.1073/pnas.0308512100 – ident: e_1_2_9_110_1 doi: 10.1007/s12031-007-0001-z – ident: e_1_2_9_16_1 doi: 10.1074/jbc.273.43.27765 – ident: e_1_2_9_70_1 doi: 10.1523/JNEUROSCI.0387-15.2015 – ident: e_1_2_9_42_1 doi: 10.1111/bpa.12699 – ident: e_1_2_9_96_1 doi: 10.1096/fj.201700359 – ident: e_1_2_9_90_1 doi: 10.1038/s41467-017-02533-w – ident: e_1_2_9_40_1 doi: 10.3389/fncel.2013.00182 – ident: e_1_2_9_136_1 doi: 10.1038/ncomms13588 – ident: e_1_2_9_49_1 doi: 10.1212/WNL.0000000000001702 – ident: e_1_2_9_138_1 doi: 10.1074/jbc.M609475200 – ident: e_1_2_9_12_1 doi: 10.1016/S0140-6736(06)69113-7 – ident: e_1_2_9_101_1 doi: 10.1016/j.neuroscience.2018.04.003 – ident: e_1_2_9_103_1 doi: 10.1074/jbc.M112.404467 – ident: e_1_2_9_160_1 doi: 10.3171/2014.11.JNS14770 – ident: e_1_2_9_151_1 doi: 10.1016/j.dadm.2018.11.002 – ident: e_1_2_9_126_1 doi: 10.1111/j.1600-0854.2009.00920.x – ident: e_1_2_9_23_1 doi: 10.1146/annurev-cellbio-101512-122326 – ident: e_1_2_9_58_1 doi: 10.1186/s13024-017-0165-0 – ident: e_1_2_9_35_1 doi: 10.1038/npjamd.2016.19 – ident: e_1_2_9_38_1 doi: 10.1016/j.jalz.2014.06.008 – ident: e_1_2_9_83_1 doi: 10.7150/thno.18133 – ident: e_1_2_9_88_1 doi: 10.1007/s12035-018-1032-x – ident: e_1_2_9_104_1 doi: 10.1074/jbc.M112.445304 – ident: e_1_2_9_105_1 doi: 10.2217/bmm-2018-0034 – ident: e_1_2_9_140_1 doi: 10.1039/C9NR01255A – ident: e_1_2_9_9_1 doi: 10.1007/s10571-019-00751-y – ident: e_1_2_9_53_1 doi: 10.1002/ana.25172 – ident: e_1_2_9_75_1 doi: 10.1042/bj3430371 – ident: e_1_2_9_123_1 doi: 10.3233/JAD-191034 – volume: 2017 start-page: 8030369 year: 2017 ident: e_1_2_9_142_1 article-title: Profiling microRNA from brain by microarray in a transgenic mouse model of Alzheimer’s disease publication-title: BioMed Research International – ident: e_1_2_9_34_1 doi: 10.1016/j.febslet.2008.05.002 – ident: e_1_2_9_95_1 doi: 10.3233/JAD-170278 – ident: e_1_2_9_130_1 doi: 10.3233/JAD-132144 – ident: e_1_2_9_61_1 doi: 10.1016/j.jalz.2016.08.012 – ident: e_1_2_9_125_1 doi: 10.1074/jbc.M110.134775 – ident: e_1_2_9_6_1 doi: 10.1038/nn.4132 – ident: e_1_2_9_112_1 doi: 10.2174/1567205016666190321155422 – ident: e_1_2_9_82_1 doi: 10.3390/ijms20071728 – ident: e_1_2_9_134_1 doi: 10.3389/fphar.2019.01452 – ident: e_1_2_9_14_1 doi: 10.1093/brain/awq258 – ident: e_1_2_9_30_1 doi: 10.1016/j.neurobiolaging.2014.02.012 – ident: e_1_2_9_74_1 doi: 10.1038/srep01197 – ident: e_1_2_9_155_1 doi: 10.1007/s11095-014-1593-y – ident: e_1_2_9_37_1 doi: 10.1016/j.biochi.2018.05.015 – ident: e_1_2_9_128_1 doi: 10.1016/j.jalz.2019.06.4952 – ident: e_1_2_9_146_1 doi: 10.1038/nature14864 – ident: e_1_2_9_145_1 doi: 10.1007/s00702-008-0177-6 – ident: e_1_2_9_50_1 doi: 10.1096/fj.201600816R – ident: e_1_2_9_32_1 doi: 10.2174/1567205014666170317113606 – ident: e_1_2_9_2_1 doi: 10.1007/s12035-019-1501-x – ident: e_1_2_9_47_1 doi: 10.1096/fj.201700731R – ident: e_1_2_9_65_1 doi: 10.1038/srep30319 – ident: e_1_2_9_102_1 doi: 10.1093/brain/awy289 – ident: e_1_2_9_122_1 doi: 10.1371/journal.pone.0198820 – ident: e_1_2_9_69_1 doi: 10.1038/cdd.2013.180 – ident: e_1_2_9_159_1 doi: 10.1016/j.jneumeth.2018.10.025 – ident: e_1_2_9_43_1 doi: 10.1186/s40035-019-0169-5 – ident: e_1_2_9_109_1 doi: 10.3233/JAD-2010-1371 – ident: e_1_2_9_156_1 doi: 10.1074/jbc.M111.324616 – ident: e_1_2_9_147_1 doi: 10.1186/s13024-017-0203-y – ident: e_1_2_9_60_1 doi: 10.1101/cshperspect.a006270 – ident: e_1_2_9_144_1 doi: 10.1016/j.neuroscience.2018.03.016 – ident: e_1_2_9_18_1 doi: 10.3389/fnins.2018.00383 – ident: e_1_2_9_87_1 doi: 10.1016/j.nbd.2018.02.014 – ident: e_1_2_9_17_1 doi: 10.3389/fnins.2019.01208 – ident: e_1_2_9_97_1 doi: 10.3233/JAD-170176 – ident: e_1_2_9_68_1 doi: 10.1016/j.jalz.2019.05.002 – ident: e_1_2_9_39_1 doi: 10.1371/journal.pbio.1001604 – ident: e_1_2_9_89_1 doi: 10.1186/gm452 – ident: e_1_2_9_52_1 doi: 10.1096/fj.201801001 – ident: e_1_2_9_26_1 doi: 10.2174/187152710793237458 – ident: e_1_2_9_81_1 doi: 10.1016/j.brainres.2018.03.034 – ident: e_1_2_9_27_1 doi: 10.1111/j.1471-4159.2008.05770.x – ident: e_1_2_9_113_1 doi: 10.3389/fncel.2019.00051 – ident: e_1_2_9_157_1 doi: 10.1074/jbc.M114.577213 – ident: e_1_2_9_3_1 doi: 10.1038/nbt.1807 – ident: e_1_2_9_25_1 doi: 10.1096/fj.201700600R – ident: e_1_2_9_73_1 doi: 10.1007/7651_2014_98 – ident: e_1_2_9_24_1 doi: 10.1038/s41598-019-45676-0 – ident: e_1_2_9_120_1 doi: 10.1016/j.cub.2012.01.028 – ident: e_1_2_9_62_1 doi: 10.1038/s41582-018-0079-7 – ident: e_1_2_9_137_1 doi: 10.1155/2016/2584940 – ident: e_1_2_9_100_1 doi: 10.1096/fj.201801319R – ident: e_1_2_9_121_1 doi: 10.1096/fj.07-9357com – ident: e_1_2_9_55_1 doi: 10.1007/s12079-019-00524-8 – ident: e_1_2_9_93_1 doi: 10.3233/JAD-180578 – ident: e_1_2_9_107_1 doi: 10.1074/jbc.M115.709485 – ident: e_1_2_9_21_1 doi: 10.3233/JAD-2008-14103 – ident: e_1_2_9_114_1 doi: 10.2217/fon-2018-0812 – ident: e_1_2_9_56_1 doi: 10.18632/oncotarget.6158 – ident: e_1_2_9_57_1 doi: 10.3390/ijms19030663 – ident: e_1_2_9_54_1 doi: 10.1093/nar/gku594 – ident: e_1_2_9_139_1 doi: 10.1074/jbc.M112.340513 – ident: e_1_2_9_99_1 doi: 10.1038/ncb2000 – ident: e_1_2_9_118_1 doi: 10.1111/j.1600-0854.2004.00257.x – volume: 31 start-page: 87 year: 2018 ident: e_1_2_9_154_1 article-title: The serum exosome derived microRNA‐135a, ‐193b, and ‐384 were potential Alzheimer’s disease biomarkers publication-title: Biomedical and Environmental Sciences – ident: e_1_2_9_15_1 doi: 10.3233/JAD-2010-1206 – ident: e_1_2_9_153_1 doi: 10.1242/jcs.215210 – ident: e_1_2_9_149_1 doi: 10.3233/JAD-180776 – ident: e_1_2_9_92_1 doi: 10.1002/hbm.23494 – ident: e_1_2_9_127_1 doi: 10.1016/S0002-9440(10)64463-X – ident: e_1_2_9_29_1 doi: 10.1007/s11064-018-2641-5 – ident: e_1_2_9_19_1 doi: 10.1038/mp.2014.127 – ident: e_1_2_9_72_1 doi: 10.1001/jamaneurol.2019.2462 – ident: e_1_2_9_106_1 doi: 10.1186/s40478-018-0514-4 – ident: e_1_2_9_22_1 doi: 10.1242/jcs.128868 – ident: e_1_2_9_86_1 doi: 10.1371/journal.pone.0139233 – ident: e_1_2_9_84_1 doi: 10.1038/s41467-019-09030-2 – ident: e_1_2_9_46_1 doi: 10.1016/j.neurobiolaging.2009.08.013 – ident: e_1_2_9_132_1 doi: 10.1126/science.1153124 – ident: e_1_2_9_48_1 doi: 10.1002/acn3.211 |
SSID | ssj0016461 |
Score | 2.643467 |
SecondaryResourceType | review_article |
Snippet | Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 162 |
SubjectTerms | Alzheimer Disease Alzheimer's Disease Animals biomarker Biomarkers diagnosis Diagnostic systems exosome Exosomes Humans miRNA Neurodegenerative diseases Pathogenesis therapeutics |
Title | Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.15112 https://www.ncbi.nlm.nih.gov/pubmed/32618370 https://www.proquest.com/docview/2484906819 https://www.proquest.com/docview/2420135400 |
Volume | 156 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1471-4159 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: HH5 dateStart: 19970101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-4159 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: DIK dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-4159 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: GX1 dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVALS databaseName: IngentaConnect Open Access Journals (Selected full-text) customDbUrl: eissn: 1471-4159 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0016461 issn: 0022-3042 databaseCode: FIJ dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.ingentaconnect.com/content/title?j_type=online&j_startat=Aa&j_endat=Af&j_pagesize=200&j_page=1 providerName: Ingenta – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0022-3042 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1471-4159 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016461 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7IXvTF27xM54gi4kul6dquw6cxFTfRB3Hgg1CaJsHh1o51A92Tf8O_5y_xJL0wbyC-lfakTZNzku_knHwBOOR15oqQC8Np1Jlh1xkzmh5rGALBPeLzBo6Jar_z9Y172bO79879Apzme2FSfohiwU1Zhh6vlYEHLJk3crQfquACjr-07ugQ7W1BHaVos2jBFI6ambEK6SyevOTnuegbwPyMV_WEc7ECD3lV0zyTp5PphJ2Esy8sjv_8l1VYzoAoaaWaswYLIlqHcitCJ3z4Qo6ITg3Va-7rsNjOj4UrQ-csTc7DYiSIOJnbwEVG8UQlH-FrY0nEc5zEQ5GQfkRag9mj6A_F-P31LSFZUGgDehfnd-1LIzuPwQhVrBgnM67pybzA4xLtNggRDbiKIt-SrBFS7uBNhBA2t2xX2LLJJHcC6nDTC1yOrvAmlKI4EttAzEAKGbqUW1TaXHqeEA7lLjel8rEkq8Bx3jN-mJGVqzMzBn7htEShr5usAgeF6Chl6PhJqJp3r58ZaeJbtmc3TRcxUQX2i8fYnCpmEkQinioZREhqbcyswFaqFsVXEPlSxR2EldWd-_vn_e5NW1_s_F10F5YslT-jl3uqUJqMp2IPAdCE1VDTO1c1re8fZUgBbA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0VOMCFfSmrQQhxSZWkSZpKXKpCVaD0gEDigqI4tgWCJoi2EnDiN_g9voQZZxFlkRC3KBknju2x3yx-BtgVVe7JSEjDrVW54VQ5N-o-rxkSwT3i8xrOibTf-azrtS-dkyv3qgQH-V6YlB-icLiRZuj5mhScHNKftRwVyCK8MAYTFJ8jtTw8L8ijiDjLKrjCcWxmvEI6jycvOroafYOYo4hVLzmtGbjOK5tmmtxVhgNeiV6-8Dj-929mYTrDoqyRDp45KMl4HhYaMdrhvWe2x3R2qHa7z8NkMz8ZbgGOD9P8PCzGwliwT3u42EMyoPwjfG2imHxK-klP9tltzBr3Lzfyticf31_f-iyLCy3CZevootk2siMZjIjCxbieCc1Q5oe-UKi6YYSAwCOWfFvxWmQJF28iinCE7XjSUXWuhBtarjD90BNoDS_BeJzEcgWYGSqpIs8StqUcoXxfStcSnjAVmVmKl2E_75ogyvjK6diM-6CwW-Io0E1Whp1C9CEl6fhJaD3v3yDT035gO75TNz2ERWXYLh5jc1LYJIxlMiQZBEnkHjPLsJyOi-IrCH4tog_Cyure_f3zwUm3qS9W_y66BZPti7NO0Dnunq7BlE3pNNr7sw7jg8eh3EA8NOCbeth_AGFIBI8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZS8QwEB48QH3xPtYziogvlbabZrv4tKwunouIgg9CaZoERbdd9gDdJ_-Gf89f4iQ98ATxrbSTNk1mkm8mky8A26LMmYyEtLxKmVu0zLlV9XnFkgjuEZ9XcEzU-53Pm-zomp7ceDdDsJ_vhUn5IYqAm7YMM15rA28L9dHI0X4cDReGYZQy9K40IrosuKM0b5ZTUIWjama0QiaNJy_6eTL6hjA_A1Yz4zSm4Dava5po8rDX7_G9aPCFxvGfPzMNkxkSJbVUdWZgSMazMFeL0QtvPZMdYnJDTdB9Fsbr-blwc3B8kGbnYTESxoJ82MFF2klPZx_haxNF5FPSTVqyS-5jUnsc3Mn7luy8vbx2SbYqNA_XjcOr-pGVHchgRXqxGGczYfjJ_NAXCg03jBAOMM2R7ypeiRzh4U3EEFS4lEmqqlwJL3Q8YfshE-gLL8BInMRyCYgdKqki5gjXUVQo35fScwQTttJOluIl2M17JogytnJ9aMZjUHgtcRSYJivBViHaTik6fhJazbs3yKy0G7jUp1WbISgqwWbxGJtTL5qEsUz6WgYhkg6O2SVYTNWi-ApCX0eTB2FlTef-_vngpFk3F8t_F92AsYuDRnB23DxdgQlX59KY0M8qjPQ6fbmGYKjH143SvwNTbQM- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+and+therapeutic+potential+of+exosomes+in+Alzheimer%E2%80%99s+disease&rft.jtitle=Journal+of+neurochemistry&rft.au=T%C3%A2nia+Soares+Martins&rft.au=Trindade%2C+D%C3%A1rio&rft.au=Vaz%2C+Margarida&rft.au=Campelo%2C+In%C3%AAs&rft.date=2021-01-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=156&rft.issue=2&rft.spage=162&rft.epage=181&rft_id=info:doi/10.1111%2Fjnc.15112&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |